Ali Zare Dehnavi on AI’s Impact on Stroke
Ali Zare Dehnavi, Clinical Innovation Adviosr at March Health, shared on LinkedIn:
”One area of AI deployment I’m particularly interested in is acute neurovascular and critical care, where time to diagnosis and team activation directly affects outcomes.
Recent work from Aidoc and Viz.ai shows what meaningful clinical AI actually looks like in practice.
Aidoc’s FDA-cleared stroke suite enables parallel triage of ischemic stroke (LVO on CTA) and intracranial hemorrhage (NCCT), with published data showing ~35–40% reductions in turnaround time for critical findings and faster escalation to treatment teams.
Viz.ai, deployed within real stroke networks, has demonstrated door-in–door-out reductions from ~200 minutes to ~105 minutes in inter-facility stroke transfers, driven by rapid LVO detection, immediate image access, and real-time team communication.
What’s notable here isn’t the algorithms in isolation, but the compression of imaging-to-decision time and earlier coordination across teams.
In stroke care, those gains translate into earlier anticoagulation, faster thrombectomy pathways, and improved functional outcomes reported in multiple centers.”
Stay updated with Hemostasis Today.
-
Apr 12, 2026, 14:493 Days, 14 Leaders, 1 Mission at The 13th EHC Youth Leadership Workshop
-
Apr 12, 2026, 14:27Moustafa Abdou: Paroxysmal Nocturnal Hemoglobinuria From a Rare Disease to a Treatable Condition
-
Apr 12, 2026, 14:18Jean Jacques Kiladjian: Grateful to the MSH for the invitation to ‘Highlights of ASH’ in Asia-Pacific 2026
-
Apr 12, 2026, 14:15Paritosh Garg: A fibrotic marrow is not always PMF
-
Apr 12, 2026, 14:13Scott Woller: ACC/AHA Guidelines and the Role of Pulmonary Embolism Response Teams
-
Apr 12, 2026, 13:55Ifeanyichukwu Ifechidere: When Fibrinogen isn’t Really Fibrinogen
-
Apr 12, 2026, 13:53Alan Nurden: A Contemporary Update on the Pathogenesis of Inherited Platelet Dysfunction
-
Apr 12, 2026, 13:47Kalyan Roy: Visual Inspection of Blood Bags and Blood Products
-
Apr 12, 2026, 13:44Francisco Ujueta: PAD VS CAD – Why Individualized Antithrombotic Strategies Matter